ABSTRACT
The epidemiology of infectious causes of meningitis in sub-Saharan Africa is not well understood, and a common cause of meningitis in this region, Mycobacterium tuberculosis (TB), is notoriously hard to diagnose. Here we show that integrating cerebrospinal fluid (CSF) metagenomic next-generation sequencing (mNGS) with a host gene expression-based machine learning classifier (MLC) enhances diagnostic accuracy for TB meningitis (TBM) and its mimics. 368 HIV-infected Ugandan adults with subacute meningitis were prospectively enrolled. Total RNA and DNA CSF mNGS libraries were sequenced to identify meningitis pathogens. In parallel, a CSF host transcriptomic MLC to distinguish between TBM and other infections was trained and then evaluated in a blinded fashion on an independent dataset. mNGS identifies an array of infectious TBM mimics (and co-infections), including emerging, treatable, and vaccine-preventable pathogens including Wesselsbron virus, Toxoplasma gondii, Streptococcus pneumoniae, Nocardia brasiliensis, measles virus and cytomegalovirus. By leveraging the specificity of mNGS and the sensitivity of an MLC created from CSF host transcriptomes, the combined assay has high sensitivity (88.9%) and specificity (86.7%) for the detection of TBM and its many mimics. Furthermore, we achieve comparable combined assay performance at sequencing depths more amenable to performing diagnostic mNGS in low resource settings.
Subject(s)
Meningitis , Mycobacterium tuberculosis , Tuberculosis, Meningeal , Central Nervous System , Humans , Meningitis/microbiology , Metagenomics , Mycobacterium tuberculosis/genetics , Tuberculosis, Meningeal/cerebrospinal fluid , Tuberculosis, Meningeal/diagnosis , Tuberculosis, Meningeal/geneticsABSTRACT
The transport and storage facilities and the potency of oral poliovirus vaccines currently administered in 108 centres in India were investigated. Storage and distribution practices in many of the centres were far from ideal. There was no significant loss of potency in the vaccine samples collected from a few centres, while samples from other centres showed a 60-99% loss of virus particles per dose. A national monitoring system has since been established to check the potency of every batch of oral poliovirus vaccine imported and to streamline the transport, storage, and administration of the vaccine. Constant vigilance as regards the quality of vaccines should ensure the success of any poliomyelitis immunization campaign.
